Company news

Illumina, Inc. news in 2025

Illumina, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Illumina To Webcast Upcoming Investor Conference

December 15, 2025

Correction: MyOme, Inc

December 14, 2025

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

November 11, 2025

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

November 9, 2025

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

November 4, 2025

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

October 29, 2025

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

October 14, 2025

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

October 14, 2025

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

October 13, 2025

Illumina launches new business to accelerate technology and data-driven discovery

September 30, 2025

Illumina advances personalized cancer care with new pharma development partnerships

September 22, 2025

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

September 17, 2025

Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows

September 10, 2025

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

September 2, 2025

Nilesh Shah joins Illumina as Head of Region, AMEA

August 19, 2025

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025

July 30, 2025

Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling

July 29, 2025

Brown Cancer Center - First In U.S. To Offer New Comprehensive Cancer Sequencing

July 16, 2025

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

July 9, 2025

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

July 9, 2025

Avance Biosciences Launches NGS Center of Excellence in Houston

June 25, 2025

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

June 22, 2025

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

June 9, 2025

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

May 28, 2025

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

May 27, 2025

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

May 12, 2025

Illumina Reports Financial Results for First Quarter of Fiscal Year 2025

May 7, 2025

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

April 30, 2025

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

April 14, 2025

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

April 9, 2025

Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

March 24, 2025

Illumina addresses recent developments in China

March 9, 2025

Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year

March 5, 2025

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

February 23, 2025

Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions

February 20, 2025

Illumina unveils first-of-its-kind spatial transcriptomics technology

February 18, 2025

Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference

February 17, 2025

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024

February 5, 2025

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025

January 13, 2025

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples

January 12, 2025

Illumina and NVIDIA collaborate to decode biology and propel precision health

January 12, 2025

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025

January 8, 2025

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications

January 6, 2025

Calls in 2025

Decks in 2025